Advertisement
Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. (EWTX) Stock Overview

Explore Edgewise Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

EWTX●NASDAQ
HealthcareBiotechnology
$37.23
$1.02(2.82%)
U.S. Market opens in 16h 7m
Advertisement

Edgewise Therapeutics, Inc. (EWTX)

Meyka AI Score

Z

Key Financials

Market Cap4B
P/E Ratio-22.00
EPS (TTM)$-1.66
ROE-0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$36.00
3 Months$10.61
1 Year Target$25.88

EWTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Edgewise Therapeutics, Inc. (EWTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.00 and a market capitalization of 4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.82%
5-Day Change
12.21%
1-Month Change
18.38%
3-Month Change
28.91%
6-Month Change
57.02%
Year-to-Date (YTD) Change
50.00%
1-Year Change
156.94%
3-Year Change
296.49%
5-Year Change
41.29%
All-Time (Max) Change
24.10%

Contact Information

https://www.edgewisetx.com
303 735 8373
3415 Colorado Avenue, Boulder, CO, 80303

Company Facts

117 Employees
IPO DateMar 26, 2021
CountryUS
Actively Trading

Frequently Asked Questions